Position in ORGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,318,557
+$5,228,891 QoQ
Shares Held
3,011,753
+241.6% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 134 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. ORGO ranks #19 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in ORGO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,318,557 | 3,011,753 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $2,089,666 | 881,717 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,323,086 | 641,523 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,982,559 | 706,768 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,624,483 | 717,072 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,861,071 | 893,767 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,870,892 | 1,522,154 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $7,752,332 | 2,710,606 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,352,527 | 2,268,760 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $3,642,662 | 1,282,628 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $4,871,160 | 1,190,993 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,905,976 | 1,542,760 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,564,097 | 1,675,933 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,436,213 | 2,552,213 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,892,619 | 2,190,565 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,174,007 | 1,288,274 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,683,712 | 345,023 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,189,177 | 156,060 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,803,158 | 195,147 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,113,226 | 78,176 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,339,538 | 80,598 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $289,461 | 15,887 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||